about
Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's DiseaseChanges in Rat 50-kHz Ultrasonic Vocalizations During Dopamine Denervation and Aging: Relevance to NeurodegenerationResveratrol: A Focus on Several Neurodegenerative DiseasesOxidative Stress in Neurodegenerative DiseasesSex differences in Parkinson's diseaseNeuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment.Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson's DiseaseToxin-Induced Experimental Models of Learning and Memory ImpairmentHyperhomocysteinemia and neurologic disorders: a reviewPesticides, microglial NOX2, and Parkinson's diseaseSpontaneously Hypertensive Rats (SHR) Are Resistant to a Reserpine-Induced Progressive Model of Parkinson's Disease: Differences in Motor Behavior, Tyrosine Hydroxylase and α-Synuclein ExpressionProtective Effects of Streblus asper Leaf Extract on H2O2-Induced ROS in SK-N-SH Cells and MPTP-Induced Parkinson's Disease-Like Symptoms in C57BL/6 MouseProgressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's diseaseLate-stage α-synuclein accumulation in TNWT-61 mouse model of Parkinson's disease detected by diffusion kurtosis imaging.Considerations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiologyTreadmill exercise alleviates depressive symptoms in rotenone-induced Parkinson disease rats.Toxicological evaluation of a rotenone derivative in rodents for clinical myocardial perfusion imaging.Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models.Stem cell transplantation in neurological diseases: improving effectiveness in animal modelsProstaglandin J2: a potential target for halting inflammation-induced neurodegeneration.Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1/eIF4E pathways, leading to neuronal apoptosis.Cucurbitacin E has neuroprotective properties and autophagic modulating activities on dopaminergic neuronsTemporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats.Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson's disease.Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state.Unexpected improvements of spatial learning and memory abilities in chronic rotenone intoxicated mice.Application of radiosurgical techniques to produce a primate model of brain lesions.1-Methyl-4-phenylpyridinium stereotactic infusion completely and specifically ablated the nigrostriatal dopaminergic pathway in rhesus macaqueLithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells.Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson's diseaseThe temporary and accumulated effects of transcranial direct current stimulation for the treatment of advanced Parkinson's disease monkeysGenetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivoNeuroprotective potential of ferulic acid in the rotenone model of Parkinson's diseaseCombination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease.Concordance analysis of microarray studies identifies representative gene expression changes in Parkinson's disease: a comparison of 33 human and animal studies.Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's diseaseQuantitation of hydrogen peroxide fluctuations and their modulation of dopamine dynamics in the rat dorsal striatum using fast-scan cyclic voltammetry.Crosstalk between Ca2+ signaling and mitochondrial H2O2 is required for rotenone inhibition of mTOR signaling pathway leading to neuronal apoptosis.Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's DiseaseRotenone-induced energy stress decompensated in ventral mesocerebrum is associated with Parkinsonism progression in rats
P2860
Q26770462-6A2DB048-6FC1-4A6D-8E8F-C8A15CD07172Q26786494-5584214B-8B6B-4FFB-B57E-AB5E80BA3D12Q26800952-40002B51-390D-44D5-8577-4E724001BEC0Q26801239-81CAE11A-E8C8-4A17-8B06-E75BF6E8A5EBQ27025107-1AEAA437-027C-4471-878D-CD71D675597EQ27303843-E3F3232C-7B81-4A5D-8451-95DBF9A61C25Q27316725-E266D961-EADA-488B-AE80-A67B31E82367Q28075913-649B141D-4E45-462B-A993-5241C3E71073Q28249880-F034DF70-E3FC-4254-9962-2FFF12530FC7Q28397585-63332025-63A8-43CD-AE40-62BF03C69C3AQ30359033-6ED237D7-9905-49B0-81CD-E0227E5756F9Q30393313-49EFA344-8D2A-4D36-9EBF-764D90160C97Q30833636-064271C2-05AF-4FA9-BCC2-643D3EB8BF27Q31032932-4BCC0EE1-E5D5-4D87-BED4-57A1FA5D600CQ33603777-681ABA4C-106F-4CCD-97CF-95667D39652DQ33625060-5B3EBE3A-FE44-42B5-9242-BEAF83BE8D2BQ33655776-626A197E-17B0-4D92-9ECF-DBACD7587625Q33790301-0A509768-D8EE-43BE-B641-C96A4E62CBA5Q34391064-911E1145-D8A5-4F91-8A1E-5029A2E88750Q34508284-4E22ADB2-F3DC-4AAF-B1DC-C667078BB0BCQ34760248-0565CFBD-DD78-4A66-9085-E564DC2F7371Q34770689-77DC1D48-0938-46B9-A3D5-9A306638ED18Q35014951-E680306F-5940-4CDF-81AE-DED1A5CC9719Q35036220-0405AB8F-02A5-4CC3-9409-FF90D83A19C2Q35053448-16EF71B0-A20A-4ADB-A2CE-0271E6A97287Q35117486-E803357E-9954-4578-8C1A-9F8F4A9D909CQ35535101-01D10BCF-5240-46C0-BFF2-F9F029F62DBCQ35641515-FE0B82CD-1AA6-419E-B8B7-8FB06BCF9DC4Q35657214-9E4ED6DC-3C80-4057-BCD1-B15AF1051AB0Q35863280-C59D769E-180B-470D-A0DE-E614BCD0424BQ35898196-DC8BDC9C-852D-4D47-A57F-50C6EB2D4193Q35912064-886CAAB1-01CB-4FDD-8143-BAAD1ECD31CCQ36156137-4AA6C821-547E-499F-B2DC-DF35EC181E8DQ36254618-1783696A-71A9-4BB1-8737-F068D0792C83Q36321061-F8B4ABE5-6CDE-4EE1-ADC6-391A4198D4B4Q36462680-B94B15C6-0848-48AE-AD12-CF409729D41DQ36851676-049A3BF4-D2C4-4A1E-9978-26FFF885D122Q36946559-D0C37D1D-AE9C-464C-98E6-924B82B9C793Q37091371-917EC1AB-94C2-45B2-A088-FAE9497E9C66Q37108659-584311E0-C422-4C59-903C-2D25D357BEBF
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Classic and new animal models of Parkinson's disease.
@ast
Classic and new animal models of Parkinson's disease.
@en
type
label
Classic and new animal models of Parkinson's disease.
@ast
Classic and new animal models of Parkinson's disease.
@en
prefLabel
Classic and new animal models of Parkinson's disease.
@ast
Classic and new animal models of Parkinson's disease.
@en
P2860
P356
P1476
Classic and new animal models of Parkinson's disease.
@en
P2093
Javier Blesa
Sudarshan Phani
P2860
P304
P356
10.1155/2012/845618
P577
2012-03-28T00:00:00Z